About Alphyn Biologics, Inc.
Alphyn Biologics is a life science company developing breakthrough therapies for skin diseases using Multi-Target Therapeutics (MTT™). Their focus is on creating first-in-class treatments for severe and common skin conditions, such as atopic dermatitis and molluscum contagiosum.
Development of Multi-Target Therapeutics (MTT™) for skin diseasesProprietary Zabalafin Platform for creating steroid-free topical treatmentsConducting clinical trials for novel therapies, including Phase 2 and Phase 2b trialsTargeting immune system and bacterial components of skin diseases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Alphyn Biologics, Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.